<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
IMNM
Immunome
$
()


  • Immunome initiated with bullish view at Guggenheim

    4/15/2024 - 06:14am
  • Immunome to presents preclinical data for IM-3050 at AACR

    4/5/2024 - 08:16am
  • Immunome files to sell 2.23M shares of common stock for holders

    4/3/2024 - 16:42pm
  • Immunome files to sell 2.18M shares of common stock for holders

    4/3/2024 - 16:38pm
  • Immunome price target raised by $6 at Wedbush, here's why

    4/1/2024 - 07:59am
  • Ayala Pharmaceuticals completes sale of AL102 to Immunome

    3/26/2024 - 08:10am
  • Shattuck Labs appoints Siegall, Sasser to board of directors

    3/4/2024 - 07:06am
  • Immunome 10M share Spot Secondary priced at $20.00

    2/14/2024 - 05:57am
  • Immunome $200M Spot Secondary; price range $20.00-$21.00

    2/13/2024 - 16:45pm
  • Immunome $200M Spot Secondary; price range $20.00-$21.00

    2/13/2024 - 16:45pm
  • Immunome announces $200M common stock offering

    2/13/2024 - 16:07pm
  • Immunome files automatic mixed securities shelf

    2/13/2024 - 16:06pm
  • Biotech Alert: Searches spiking for these stocks today

    2/9/2024 - 11:12am
  • Immunome to acquire AL102 from Ayala for $20M in cash, $30M in stock

    2/6/2024 - 08:21am
  • Immunome acquires AL102 a and AL101 from Ayala for $50M at closing

    2/6/2024 - 08:06am
dynamic_feed Breaking News